This post is sponsored by CED.
Individuals and companies may now register for partnering sessions at the CED Life Science Conference on February 15-16, 2012, held at the Raleigh Convention Center in Raleigh, NC. The partnering sessions will be open to all conference participants, and priority consideration will be given to those who register early.
“We participated in two partnering sessions in 2011 that were quite constructive and vital for moving our company forward to potential licensing discussions,” said Steven E. Peterson, CEO of Trana Discovery, Inc. Peterson plans to participate in the partnering sessions in 2012, as well.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Corporate partners confirmed for the conference include Abbott, BASF, Bayer Crop Science, GlaxoSmithKline, LabCorp, Merck, Novartis, and United Therapeutics. In addition to requesting opportunities to schedule 30-minute private networking meetings with these companies, participants also will have the opportunity to request meetings with investors, emerging life science companies and university technology transfer officers.
“Anytime we can bring people together to partner in forums such as this, we open doors to significant collaborations and opportunities to commercialize important new technologies,” said Norris Tolson, president and CEO of the North Carolina Biotechnology Center.
The CED Life Science Conference 2012 is presented in partnership with the North Carolina Biotechnology Center and North Carolina Biosciences Organization. Early registration and a full conference agenda can be found online at: http://www.cednc.org/lifescience.
Note: CED is running a special promotion — anyone who registers prior to 2012 will be entered to win a free conference pass (for themselves or a colleague). Act now for your chance to win!
